Platform & Pipeline

We are currently developing the Gradalis immunotherapy in a number of advanced cancer indications, including:

Program
Preclinical
IND
Phase I
Phase II
Phase III
Gradalis Immunotherapy Platform
Advanced Ovarian
Ewing's Sarcoma
Advanced Breast Cancer
Advanced Non-Small Cell Lung Cancer
Advanced Melanoma
Gradalis® Development Pipeline